Gregory A Light Selected Research

Cognitive Training

1/2022	The viability of the frequency following response characteristics for use as biomarkers of cognitive therapeutics in schizophrenia.
11/2021	Evaluation of the frequency following response as a predictive biomarker of response to cognitive training in schizophrenia.
11/2021	Contextualizing the road to recovery: A novel method of assessing outcome trajectories in clinical trials.
10/2021	Central auditory processing deficits in schizophrenia: Effects of auditory-based cognitive training.
4/2021	Auditory discrimination and frequency modulation learning in schizophrenia patients: amphetamine within-subject dose response and time course.
11/2020	Gamma oscillations predict pro-cognitive and clinical response to auditory-based cognitive training in schizophrenia.
1/2020	Oscillatory biomarkers of early auditory information processing predict cognitive gains following targeted cognitive training in schizophrenia patients.
1/2019	Verbal learning deficits associated with increased anticholinergic burden are attenuated with targeted cognitive training in treatment refractory schizophrenia patients.
1/2019	Divergence of subjective and performance-based cognitive gains following cognitive training in schizophrenia.
1/2019	Neurophysiologic measures of target engagement predict response to auditory-based cognitive training in treatment refractory schizophrenia.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gregory A Light Research Topics

Disease

60	Schizophrenia (Dementia Praecox) 01/2022 - 06/2004
11	Psychotic Disorders (Schizoaffective Disorder) 01/2022 - 09/2013
8	Cognitive Dysfunction 01/2021 - 07/2005
3	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 07/2005
3	Treatment-Resistant Schizophrenia 01/2019 - 12/2018
2	Mental Disorders (Mental Disorder) 03/2022 - 12/2019
2	Neurodevelopmental Disorders 01/2022 - 01/2014
2	Brain Diseases (Brain Disorder) 12/2020 - 01/2014
1	Abdominal Pain (Pain, Abdominal) 01/2022
1	Diarrhea 01/2022
1	Fatigue 01/2022
1	Headache (Headaches) 01/2022
1	Nausea 01/2022
1	Dementia (Dementias) 01/2021
1	Hypoxia (Hypoxemia) 01/2020
1	Symptom Flare Up 12/2019
1	Bipolar Disorder (Manic Depressive Psychosis) 11/2015

Drug/Important Bio-Agent (IBA)

26	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2009
8	Antipsychotic Agents (Antipsychotics)IBA 01/2022 - 06/2004
6	Memantine (Namenda)FDA Link 01/2021 - 01/2016
4	Pharmaceutical PreparationsIBA 04/2021 - 01/2016
4	Amphetamine (Amfetamine)FDA LinkGeneric 04/2021 - 01/2017
4	Biological ProductsIBA 12/2019 - 01/2007
2	Donepezil (Aricept)FDA LinkGeneric 01/2022 - 07/2005
2	Cholinergic Antagonists (Anticholinergics)IBA 01/2021 - 01/2019
1	Adenosine Monophosphate (AMP)IBA 01/2022
1	Glutamate Receptors (Glutamate Receptor)IBA 01/2022
1	Cholinergic Agents (Cholinergics)IBA 01/2022
1	Muscarinic M1 ReceptorIBA 01/2022
1	Sp4 Transcription FactorIBA 01/2022
1	Dopamine D1 Receptors (Dopamine D1 Receptor)IBA 01/2021
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 12/2020
1	ParvalbuminsIBA 12/2020
1	gamma-Aminobutyric Acid (GABA)IBA 12/2020
1	Aminobutyrates (Aminobutyric Acid)IBA 12/2020
1	Oxygen (Dioxygen)IBA 01/2020
1	Psychotropic Drugs (Psychoactive Drugs)IBA 12/2019
1	bis(p-chlorophenyl)acetic acid (DDA)IBA 01/2019
1	Dextroamphetamine (Dexedrine)FDA LinkGeneric 01/2018
1	Therapeutic UsesIBA 01/2017
1	Ketamine FDA LinkGeneric 01/2016
1	N-Methylaspartate (NMDA)IBA 01/2016
1	Proteins (Proteins, Gene)FDA Link 11/2015
1	Transcription Factors (Transcription Factor)IBA 11/2015
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 04/2015
1	salicylhydroxamic acid (SHAM)IBA 12/2013
1	Glutamic Acid (Glutamate)FDA Link 09/2011
1	DNA (Deoxyribonucleic Acid)IBA 02/2008
1	Risperidone (Risperdal Consta)FDA LinkGeneric 09/2007
1	Haloperidol (Haldol)FDA LinkGeneric 09/2007
1	Olanzapine (Zyprexa)FDA Link 09/2007
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 07/2005

Therapy/Procedure

17	Cognitive Training 01/2022 - 04/2016
8	Therapeutics 03/2022 - 07/2005
2	Electrodes (Electrode) 01/2021 - 10/2012
1	Precision Medicine 01/2018
1	Drug Therapy (Chemotherapy) 06/2004